Table 3 Past preventive migraine medication. Patients are shown by N (%), treatment duration by µ ± SD [months]. Percentages may not sum up to 100% in case of missing data

Any prior preventive therapy

153 (100%)

N.A

Beta-blockers

132 (86.3%)

13.5 ± 23.3

Calcium Channel Blockers

88 (57.5%)

4.5 ± 7.1

Anticonvulsants

144 (94.1%)

9.4 ± 16.2

Antidepressants

141 (92.2%)

10.6 ± 17.6

Onabotulinumtoxin A

83 (54.2%)

10.6 ± 14.2

Any anti-CGRP pathway mAb

153 (100%)

N.A

 Erenumab 70 mg

93 (60.8%)

6.4 ± 6.7

 Erenumab 140 mg

110 (71.9%)

8.5 ± 7.1

 Any erenumab

145 (94.8%)

10.6 ± 8.8

 Galcanezumab

16 (10.5%)

7.4 ± 3.6